Print

Ambry Genetics Reports Specific Results from Clinical Diagnostic Exome™ Testing of Patients at Kennedy Krieger Institute  
2/29/2012 7:04:51 AM

ALISO VIEJO, Calif. & BALTIMORE--(BUSINESS WIRE)--Ambry Genetics, a global leader in genetic services with a focus on clinical diagnostics and genomics, announces specific results from one of three recent diagnoses using its proprietary new Clinical Diagnostic Exome™. Four individuals with rare genetic conditions for which the cause could not previously be identified were successfully diagnosed, three at Kennedy Krieger Institute in Baltimore and one at a large, Ivy League-affiliated university hospital in New York City.
//-->